http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0458535-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0d78cd2835221849f6a74e6349185819
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-05
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-05
filingDate 1991-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_140305274c02cfc3e40f571252d8e120
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06f83d87063e4fb731949240b3c59506
publicationDate 1991-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0458535-A2
titleOfInvention Therapeutic product for the treatment of cystic fibrosis
abstract There is provided a novel therapeutic product for use in the symptomatic treatment of cystic fibrosis and for use in the manufacture of a medicament for the treatment of cystic fibrosis, as well as a method of treatment of cystic fibrosis with the therapeutic product and a method of treatment of cystic fibrosis with the therapeutic product in combination with one or more other agents indicated for the treatment of cystic fibrosis.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9222309-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5767084-A
priorityDate 1990-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0291234-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0345906-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0189305-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8600077-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0276101-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0369391-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0402068-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0337704-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16231
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453459407
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360545
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523291
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5462222
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID131712986
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226415114
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559553
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505358
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID977
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID159087
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559508
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419524818

Total number of triples: 40.